Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations



Rating:

Share or cite this content

Citations should be made in the following way:
Jan Van Meerbeeck (Antwerp, Belgium), Isabelle Opitz (Zurich, CH), Matthias Guckenberger (Zurich, CH), Jo Raskin (Antwerp, Belgium). COVID-19 and the management of thoracic cancer patients: challenges and recommendations. ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations

Member's Comments

No comment yet.

Related content which might interest you: An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Lung cancer: the importance of seeing a respiratory physician Source: Eur Respir J 2003; 21: 606-610 Year: 2003 Lung cancer in COPD Source: Eur Respir Mon 2013; 59: 174-188 Year: 2013 Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases Source: ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases Year: 2021 The need for early MDT assessment of lung cancer patients presenting with pain Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Challenges in molecular testing in lung cancer patients with advanced disease Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Missed lung cancer on chest radiography – does it affect the outcome? Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 The approach to the surgical management of cancer in four European countries Source: Eur Respir J 2003; 22: 838-844 Year: 2003 Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014 New and anticipated therapeutic developments in management of non-small-cell lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013